Author

Chun Nan Lok

University of Hong Kong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alice S.T. WongiD· 1 shared Ayon Ahmed HassaniD· 1 shared Chenhui ZhangiD· 1 shared Chi‐Ming CheiD· 1 shared Katie Sze Wai Fung· 1 shared Lydia W.T. CheungiD· 1 shared Nan LiuiD· 1 shared Philip P.C. IpiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice S.T. WongORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer-specific sialylation of insulin-like growth factor 1 receptor impairs therapeutic antibody binding and efficacy

Ayon Ahmed Hassan, Qiushi Chen, Katie Sze Wai Fung, Sally Kit Yan To, Lydia W.T. Cheung, Chenhui Zhang, Nan Liu, Chun Nan Lok, Chi‐Ming Che, Philip P.C. Ip, Xuechen Li, Alice S.T. Wong

This paper shows that cancer-specific sialylation of IGF1R reduces ganitumab binding and efficacy, and that desialylation enhances therapeutic response.

bioRxiv · Oct 17, 2025 · PreprintCancer Biology